Connect Sign In
Each year, the ARUP Institute for Clinical and Experimental Pathology® presents at more than 200 conferences, workshops, annual meetings, and symposiums for several national and international organizations. Recent posters and presentations are listed below.
University of Oklahoma Infectious Diseases Conference Series
Norman, OK, April 22, 2026
Mathison BA—Presentation
Mathison BA. Medical entomology, myiasis, and the re-emergence of the New World screwworm fly.
South Central Association for Clinical Microbiology Spring Meeting
Indianapolis, IN, April 14–16, 2026
Mathison BA—Presentation
Mathison BA. Fun and unusual parasitology cases.
Mathison BA—Presentation
Mathison BA. Case-based algorithms in clinical parasitology.
Global Conference on Myositis
Lisbon, Portugal, March 23–26, 2026
Martins TB, Ghazaryan A, Toninelli M, Lin L, Smith T, Peterson L—Poster
Martins TB, Ghazaryan A, Toninelli M, Lin L, Lebiedz-Odrobina D, Smith T, Peterson L. Performance of particle-based multi-analyte technology for the detection of myositis specific antibodies in both selected and unselected cohorts.
United States and Canadian Academy of Pathology (USCAP)
San Antonio, TX, March 21–26, 2026
Wilcock DM, Rets A, Jacobsen J, Shestakova G—Poster
Wilcock DM, Rets A, Jacobsen J, Shestakova G. Clinical utility of FISH testing for 11q aberration in MYC-negative high-grade/large B-cell lymphomas of germinal center immunophenotype.
Moscon J, Hale G, Evason K, Kikuchi A—Presentation
Moscon J, Hale G, Evason K, Kikuchi A. Periostin immunohistochemical evaluation of tumor associated stroma for diagnostic distinction of intrahepatic cholangiocarcinoma from benign biliary proliferations: a pilot study.
Barnes S, Daines JM, Gulbahce HE, Mahlow J—Poster
Barnes S, Daines JM, Gulbahce HE, Mahlow J. Revisiting the clinicopathologic characteristics of encapsulated papillary carcinoma and rates of invasion.
Thrombosis and Hemostasis Summit of North America (THSNA)
Portland, OR, March 18, 2026
Moser KA—Presentation
Moser KA. Interesting coagulation cases: ISLH/NASCOLA premeeting workshop.
American College of Medical Genetics and Genomics (ACMG)
Baltimore, MD, March 10, 2026
Zhang R, LaGrave D, Rudd MK—Poster
Zhang R, LaGrave D, Procko A, Rudd MK. Maternal mosaic unbalanced translocation detected after atypical cfDNA screen.
Utah Valley University’s Physician Assistant Program
Orem, UT, January 21, 2026
Mathison BA—Presentation
Mathison BA. Introduction to parasitology.
Johns Hopkins Clinical Microbiology Seminar Series
Baltimore, MD, January 20, 2026
Mathison BA—Presentation
Mathison BA. Use of artificial intelligence for the detection of parasites in human stool specimens.
American Society of Hematology (ASH)
Orlando, FL, December 6–9, 2025
Deshotel M, Li P, Williams M, Rets A, Karner K, Saadalla A, George T, Shestakova A—Poster
Deshotel M, Li P, Williams M, Rets A, Karner K, Saadalla A, George T, Shestakova A. Testing for hereditary alpha-tryptasemia (HαT)/TPSAB1 copy number analysis by ddPCR: genotypes and phenotypes one year after TPSAB1 assay go-live.
Human Genomic Seminar Series at UC Davis
UC Davis (Virtual Meeting), December 3, 2025
Hong B—Presentation
Hong B. Clinical cytogenetics: essential insights for diagnosis, prognosis, and therapeutic innovation.
ARUP Institute for Learning
Salt Lake City, UT, December 2, 2025
Mathison BA—Presentation
Mathison BA. Applications for artificial intelligence in the clinical parasitology laboratory.
American Society for Clinical Pathology (ASCP)
Atlanta, GA, November 17–20, 2025
Moser KA—Presentation
Moser KA. Rapid review series: coagulation.
Nelson HA—Presentation
Sandoval C, Nelson HA. Plasma-based diagnostics for Alzheimer's evaluation: navigating an evolving landscape.
Hird K—Poster
Hird K, Sakr R, Goodwill V, Hansen L, Trivedi U, Robinson A, Lei L. Synchronous olfactory neuroblastoma and olfactory carcinoma with genetic evidence of common clonal origin: a case report.
American Medical Informatics Association (AMIA)
Atlanta, GA, November 15–19, 2025
Rychert J—Presentation
Rallins M, Skapik J, Rychert J, Banning P, Emrick S. SHIELD as a mechanism to support the adoption of LOINC and SNOMED CT standards for laboratory data interoperability.
Association for Molecular Pathology (AMP)
Boston, MA, November 11–15, 2025
Bethers H, Clark S, Del Angel S, Fredrickson F, Margraf B, Meadows C, Shaaban S, Sibio S—Presentation
Bethers H, Clark S, Del Angel S, Fredrickson F, Margraf B, Meadows C, Shaaban S, Sibio S. Pharmacogenetics 87-variant genotyping panel based on AMP two-tier strategy for clinical testing.
Deshotel MJ, Reading NS, Fredrickson E, Close D, Ji Y—Presentation
Deshotel MJ, Reading NS, Fredrickson E, Close D, Ji Y. Asuragen early access program (EAP): the ARUP Laboratories experience.
Tardif KD, Hymas WC, Bradley BT—Presentation
Tardif KD, Hymas WC, Bradley BT. Validation of influenza A (H1 and H3) subtyping on the Hologic Panther Fusion system.
de Hart N—Presentation
de Hart N. Project management strategies in clinical settings.
Reading NS, Deshotel MJ, Frederickson E, Close D, Ji Y—Poster
Reading NS, Deshotel MJ, Frederickson E, Close D, Ji Y. Use of long-range sequencing in carrier screening: a single-site evaluation.
Bui H, Lewis T, Joe S, Deshotel M, Pattison D, Yang L, Kellogg A, Kazan J, Fredrickson E, Rindler P, Bolia A, Pizzo L, Mao R, Andersen EF, Best H—Poster
Bui H, Lewis T, Joe S, Deshotel M, Pattison D, Yang L, Kellogg A, Kazan J, Fredrickson E, Rindler P, Bolia A, Pizzo L, Mao R, Andersen EF, Best H. Analytical validation of germline variant classes using PCR-free whole genome sequencing.
Liew M, Schumacher J, Ly D, Hellwig S, Shestakova A, George T, Li P—Poster
Liew M, Schumacher J, Tsewang T, Ly D, Hellwig S, Shestakova A, Berthier E, George T, Li P. Validation of a patient-centric collection technology for ddPCR detection of the KITD816V mutation.
NSGC National Society of Genetic Counselors
Seattle, WA, November 7–10, 2025
Openshaw AS, Rudd MK—Poster
Openshaw AS, Rudd MK. Additional cell counts do not usually identify low-level mosaicism in amniotic fluid after atypical mosaic cfDNA screening results.
17th International Congress of Myeloproliferative Neoplasms
Brooklyn, NY, November 6–7, 2025
George TI—Poster
Siebenhaar F, Alvarez-Twose I, Sundaresh V, Hartmann K, Maurer M, Broesby-Olsen S, Akin C, George TI, Lin HM, Lampson B, Gotlib J. Avapritinib and bone health in indolent systemic mastocytosis: learnings from the PIONEER trial.
American Society of Nephrology
Houston, TX, November 5–9, 2025
Bajaj AO, Kushnir MM, McMillin GA, Doyle K—Presentation
Akramimoghaddam F, Boucher R, Bajaj AO, Kushnir MM, McMillin GA, Doyle K, Beddhu S. Associations of plasma ceramides with adipose tissue, plasma and urinary markers of inflammation and oxidative stress in CKD.
ESGCP and ESGITM Parasite Morphology Hub Webinar Series
Salt Lake City, UT [live, virtual], October 30, 2025
Mathison BA—Presentation
Mathison BA. Worms I have known: weird/esoteric cases involving histology.
2025 Fall Clinical Dermatology Conference
Las Vegas, NV, October 23–26, 2025
George TI—Poster
Siebenhaar F, Broesby-Olsen S, George TI, Elberink HO, Oh S, Lin HM, Bidollari I, Hong J, Madigan L, Hartmann K. Avapritinib durably improves cutaneous involvement of indolent systemic mastocytosis in patients treated in the PIONEER study.
Southeastern Allergy, Asthma, and Immunology Conference
White Sulphur Springs, WV, October 23–25, 2025
George TI—Poster
Elberink HO, Akin C, Castells M, Gotlib J, Panse J, Radia DH, Siebenhaar F, Tashi T, Livideanu CB, Hartmann K, Broesby-Olsen S, George TI, Sabato V, Van Daele P. Cerquozzi S, Dybedal I, Jurcic J, Barete S, Reiter A, Pongdee T, Desai R, Schafhausen P, Ustun C, Bose P, Vadas P, Triggiani M, Bonadonna P, DeAngelo DJ, Rein L, Vachhani P, Bidollari I, Lin HM, Hong J, Lampson B, Doyle A, Alvarez-Twose I. Favorable benefit-risk profile of Avapritinib in indolent systemic mastocytosis is maintained after 3 years of therapy: longer-term analysis of the PIONEER study.
ADLM Preanalytical Phase Conference
Providence, RI, October 23–24, 2025
Cheng W, Rychert J, Spies NC—Poster
Cheng W, Rychert J, Spies NC. Large language models fail to map laboratory test names to LOINC codes.
National Association of Medical Examiners
Louisville, KY, October 17–21, 2025
Schmitt J—Poster
Schmitt J, Marsden L, Duncanson ER, Mackey-Bojack S, Krehbiel KA. Left ventricular-dominant arrhythmogenic cardiomyopathy, active phase: two case reports highlighting genetic and pathologic insights.
California Association for Medical Laboratory Technology Annual Meeting
Sacramento, CA, October 17–18, 2025
Nelson HA—Presentation
Nelson HA. Advancing Alzheimer’s diagnosis: the role of fluid biomarkers and plasma pTau217.
American Society of Human Genetics (ASHG)
Boston, MA, October 14–18, 2025
Lewis ZK, Pizzo L, Clayton A, Hong B, Zhao J, Rudd K, Andersen EF—Poster
Lewis ZK, Pizzo L, Clayton A, Hong B, Zhao J, Rudd K, Andersen EF. Secondary findings in clinical genomic microarray – reporting strategies and experiences from constitutional and oncology settings.
Pizzo L, Lewis ZK, Reich D, Andersen EF—Poster
Pizzo L, Lewis ZK, Reich D, Andersen EF. Classifying non-coding structural variants for clinical genomics.
Deutscher Allergiekongress
Düsseldorf, Germany, October 2–4, 2025
George TI—Poster
Siebenhaar F, Elberink HO, Akin C, Castells M, Gotlib J, Panse J, Radia DH, Tsewang T, Livideanu CB, Hartmann K, Broesby-Olsen S, George TI, Sabato V, Van Daele P, Cerquozzi S, Dybedal I, Jurcic J, Barete S, Reiter A, Pongdee T, Desai R, Schafhausen P, Ustun C, Bose P, Vadas P, Triggiani M, Bonadonna P, DeAngelo DJ, Rein L, Vachhani P, Bidollari I, Lin HM, Hong J, Lampson B, Doyle A, Alvarez-Twose I. Long-term data from the PIONEER study: favorable benefit-risk profile of Avapritinib in indolent systemic mastocytosis is maintained even after 3 years of therapy.
International Clinical Cytometry Society (ICCS)
Philadelphia, PA, September 28–30, 2025
Davis PM, Cherrington WH, Ng DP, Jacobsen JR—Poster
Davis PM, Cherrington WH, Ng DP, Jacobsen JR. Evaluation of Stage 0 Hematogones Using a 28-Marker Spectral B-cell Lymphoblastic Leukemia Panel.
Ravkov EV, De Juan JD, Gudipaty S, Abbott GV, Lin L—Poster
Ravkov EV, De Juan JD, Gudipaty S, Abbott GV, Lin L. Conversion of lymphocyte subsets assay from 3 to 1 tube format.
8th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma
New York, NY, September 26–28, 2025
Daines J, Szankasi P, Menon M, Jacobsen JR, Miles RR—Poster
Daines J, Ghosh T, Mims L, Szankasi P, Menon M, Jacobsen JR, Miles RR. EBV-Positive Gray Zone Lymphoma In A Pediatric Patient.
Mass Spectrometry: Applications to the Clinical Laboratory (MSACL)
Montreal, Canada, September 21–26, 2025
Kushnir MM—Presentation
Liang Z, Wu Y, Kushnir MM, Yang YK. Bioinformatics Pipeline for Targeted Glycosylation Profiling in Intact Protein Mass Spectrometry.
Kushnir MM—Presentation
Kushnir MM, Salihovic S, Bergquist J, Lind PM, Lind L. Environmental Pollutants and Sex Hormones in Elderly: A Cross-Sectional Population Study.
Kushnir MM—Presentation
Thorsteinsdóttir M, Eiriksson FF, Kushnir MM. Design of Experiments for Optimization of LC-MS Clinical Assays.
Schramm K, Ray JA, Kushnir MM, Yuzyuk T—Poster
Schramm K, Ray JA, Kushnir MM, Vachali P, Yuzyuk T. Monitoring UDCA and other Bile Acids in Intrahepatic Cholestasis of Pregnancy may improve clinical outcomes.
Ray JA, Merrigan SD, McMillin G, Fisher MA, Johnson Davis KL—Presentation
Ray JA, Merrigan SD, Vachali P, Bates T, Aventura Z, Putnam S, McMillin G, Fisher MA, Johnson Davis KL. A Proof-of Concept Study: Measuring Antifungals in Human Serum Using Direct Analysis in Real Time-Mass Spectrometry (DART-MS).
Smith D, Hughs M, McMillin G, Boyd J—Presentation
Smith D, Hughs M, McMillin G, Boyd J. Quantitation of perfluoroalkyl compounds in human serum/plasma by LC/MS/MS.
Ray JA—Presentation
Ray JA. A proof-of-concept study: measuring antifungals in human serum using direct analysis in real time-mass spectrometry (DART-MS).
Jensen MS, Pasquali M—Poster
Jensen MS, Pasquali M. Impact of collection tube type on amino acid concentration: plasma and serum.
Merrigan SD, Kushnir MM, and Frank EL—Poster
Merrigan SD, Kushnir MM, and Frank EL. Quantification of plasma nicotinic acid and two metabolites by LC-MS/MS.
Bajaj AO, Kushnir MM, Doyle K—Poster
Bajaj AO, Kushnir MM, Vachali P, Steckel S, McMillin G, Doyle K. Quantitative LC-MS/MS assay for ceramides in plasma and serum: development, validation, and performance evaluation.
Northeast Association for Clinical Microbiology and Infectious Diseases (NACMID)
Nashua, NH, September 21–26, 2025
Mathison BA—Presentation
Mathison BA. Laboratory Identification of Blood Parasites.
European Competence Network on Mastocytosis
London, United Kingdom, September 18–20, 2025
George TI—Presentation
George TI, Schwaab J. Prognostication and efficacy of novel TKIs in SM.
George TI, Rets A, Patel J, Menon M, Moser K—Presentation
George TI, Rets A, Patel J, Menon M, Moser K. Histopathological and phenotypic changes of mast cells during TKI therapy.
Society for Hematopathology and European Association for Hematopathology
Cincinnati, OH, September 4–6, 2025
Miles RR, Jacobsen JR, Smock KJ—Presentation
Miles RR, Jacobsen JR, Smock KJ, Cessna MH, Dewyze L, Taylor A. Acute megakaryoblastic leukemia with GATA1 mutation.
Southwestern Association of Clinical Microbiology
Dallas, TX, September 3–5, 2025
Mathison BA—Presentation
Mathison BA. Diagnostic Parasitology Algorithms.
International Congress of Inborn Errors of Metabolism (ICIEM)
Kyoto, Japan, September 2–6, 2025
Pasquali M, Saffary Y—Poster
Pasquali M, Saffary Y, Ames E, Fisher R, Maegawa G, Botto L, Longo N. Chondroitin sulfate non-reducing ends for the diagnosis of the slowly progressive form of mucopolysaccharidosis type 4A.
